Patent · US Active

Interferon beta antibodies and uses thereof

US10829553B2 · kind B2 · utility

1Cited by

2References

17Claims

0Family size

Assignees

PFIZER INC. · US
The Brigham and Women's Hospital, Inc. · US

Inventors

Stefano V. Gulla · Boston, US
Christine Huard · Somerville, US
Janet Elizabeth Buhlmann · Brookline, US
Juan Carlos Almagro · Brookline, US
Sreekumar R. Kodangattil · Lexington, US
Steven A. Greenberg · Newton, US
Edward R. LaVallie · Harvard, US
Eric M. Bennett · Arlington, US
Lidia Mosyak · Newton, US
James Perry Hall · Stow, US
Anthony Coyle · Washington, US

Key dates

Filing date	Apr 28, 2017
Grant date	Nov 10, 2020
Priority date	—
Expiry date	Jul 5, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNβ). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.